Healthcare Business
Latest News
Zongertinib Granted Accelerated Approval in Nonsquamous NSCLC for HER2 TKD-Activating Mutations
Zongertinib gains FDA approval for treating HER2-mutated non–small cell lung cancer (NSCLC), offering hope with fewer side effects and promising respo...
Understanding FAS: From Pregnancy Risks to Lifelong Care
Fetal alcohol syndrome (FAS) is 100% preventable as an environmental cause of intellectual disability and represents the most severe form of fetal alc...
Tafasitamab Approval Expands Chemotherapy-Free Treatment Options for R/R Follicular Lymphoma: Christina Poh, MD
Christina Poh, MD, of City of Hope National Medical Center, highlights the benefit of tafasitamab in improving progression-free survival for heavily p...
Availity, Onyx Launch Turnkey Solution to Meet Prior Authorization, Interoperability Rule
A new partnership delivers a scalable Fast Healthcare Interoperability Resources solution to help payers meet CMS' Interoperability and Prior Authoriz...
Left Bundle Branch Block May Be Key Indicator of Progressive Heart Failure
Left bundle branch block may serve as an important indicator for asymptomatic individuals predisposed to heart failure.
Social Drivers of Health Can Impact Regular Exercise, Increase CVD Risk: Melvin Echols, MD
Social drivers of health are determined primarily by an individual’s economic stability, access to quality education, and health care. These factors a...
Addressing Unmet Needs in Lung Cancer to Optimize Precision Medicine and Immunotherapy: Angel Qin, MD
Angel Qin, MD, identified the critical role of immunotherapy timing and shared decision-making in small cell lung cancer while also addressing the nee...
Why Human Oversight Matters When Implementing AI in Diabetes Care: Marry Vuong, PharmD, BCPPS
Artificial intelligence–powered insulin dosing and virtual coaching offer faster answers and convenience, but accuracy and oversight are key to buildi...
Exploring the Potential of Machine Learning in Optimizing Respiratory Failure Treatment
Machine learning holds promise for optimizing treatment strategies and potentially improving outcomes in respiratory failure but future research and d...
Enfortumab Vedotin Plus Pembro Boosts Survival in Key Groups With Bladder Cancer Before and After Surgery, Phase 3 Study Finds
Topline results, to be presented at an upcoming congress, show enfortumab vedotin and pembrolizumab significantly improve survival for muscle-invasive...
Zongertinib Granted Accelerated Approval in Nonsquamous NSCLC for HER2 TKD-Activating Mutations
Understanding FAS: From Pregnancy Risks to Lifelong Care
Tafasitamab Approval Expands Chemotherapy-Free Treatment Options for R/R Follicular Lymphoma: Christina Poh, MD
Availity, Onyx Launch Turnkey Solution to Meet Prior Authorization, Interoperability Rule
Left Bundle Branch Block May Be Key Indicator of Progressive Heart Failure
Social Drivers of Health Can Impact Regular Exercise, Increase CVD Risk: Melvin Echols, MD
Addressing Unmet Needs in Lung Cancer to Optimize Precision Medicine and Immunotherapy: Angel Qin, MD
Why Human Oversight Matters When Implementing AI in Diabetes Care: Marry Vuong, PharmD, BCPPS
Exploring the Potential of Machine Learning in Optimizing Respiratory Failure Treatment
Enfortumab Vedotin Plus Pembro Boosts Survival in Key Groups With Bladder Cancer Before and After Surgery, Phase 3 Study Finds
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago